Aquarius Surgical Technologies Inc. (TSE:ASTI)

:ASTI

ASTI

Aquarius Surgical Technologies

RESEARCH TOOLSreports

Aquarius Surgical Technologies (ASTI) Price & Analysis

1 Followers

ASTI Stock Chart & Stats

C$0.01

C$0.00(0.00%)

At close: Dec 06 4:00 PM EST

C$0.01

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.01 - C$0.03

Previous CloseN/A

Volume0.00

Average Volume (3M)6.90K

Market Cap

C$275.99K

Enterprise ValueC$6.84M

Total Cash (Recent Filing)C$14.28K

Total Debt (Recent Filing)C$6.58M

Price to Earnings (P/E)0.2

Beta1.14

Next Earnings

Aug 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding27,599,173

10 Day Avg. Volume4,405

30 Day Avg. Volume6,901

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)-0.10

Price to Sales (P/S)6.05

P/FCF Ratio-1.44

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Industry ExposureAquarius operates in the Medical - Devices industry, a structural sector underpinned by ongoing healthcare demand and long product lifecycles. That exposure can provide a more stable long-term revenue base and lower cyclicality risk if the company can stabilize execution.

Reporting Cadence / TransparencyThe company maintains scheduled public reporting (NextEarningReleaseDate: 2026-08-03), reflecting regulatory compliance and governance. Regular disclosures support investor oversight and facilitate access to capital and strategic decisions during a multi-month turnaround period.

FCF Alignment With Net IncomeFree cash flow to net income ratio of 1.0 indicates reported losses are aligned with cash outflows rather than driven primarily by noncash accounting items. That alignment improves visibility into cash needs and reduces the risk of surprise noncash adjustments during recovery planning.

Bears Say

Declining RevenueRevenue decline of -17.1% combined with a negative net margin (-12.8%) signals weakening demand and persistent unprofitability. Continued top-line contraction erodes operating leverage, limits reinvestment, and makes sustainable margin recovery difficult without structural product or market improvements.

Negative Stockholders' EquityNegative stockholders' equity means liabilities exceed assets, a structural solvency concern. This condition restricts borrowing capacity, increases refinancing and covenant risk, and materially reduces strategic flexibility unless capital is injected or liabilities restructured.

Negative Operating & Free Cash FlowPersistent negative operating and free cash flows indicate the business consumes cash from core operations. That liquidity drain forces reliance on external financing or asset disposals, raising the likelihood of dilution or distress and constraining investment for at least several months.

ASTI FAQ

What was Aquarius Surgical Technologies Inc.’s price range in the past 12 months?

Aquarius Surgical Technologies Inc. lowest stock price was C$0.01 and its highest was C$0.03 in the past 12 months.

What is Aquarius Surgical Technologies Inc.’s market cap?

Aquarius Surgical Technologies Inc.’s market cap is C$275.99K.

When is Aquarius Surgical Technologies Inc.’s upcoming earnings report date?

Aquarius Surgical Technologies Inc.’s upcoming earnings report date is Aug 03, 2026 which is in 116 days.

How were Aquarius Surgical Technologies Inc.’s earnings last quarter?

Aquarius Surgical Technologies Inc. released its earnings results on Feb 24, 2026. The company reported -C$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.021.

Is Aquarius Surgical Technologies Inc. overvalued?

According to Wall Street analysts Aquarius Surgical Technologies Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aquarius Surgical Technologies Inc. pay dividends?

Aquarius Surgical Technologies Inc. does not currently pay dividends.

What is Aquarius Surgical Technologies Inc.’s EPS estimate?

Aquarius Surgical Technologies Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aquarius Surgical Technologies Inc. have?

Aquarius Surgical Technologies Inc. has 27,599,173 shares outstanding.

What happened to Aquarius Surgical Technologies Inc.’s price movement after its last earnings report?

Aquarius Surgical Technologies Inc. reported an EPS of -C$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Aquarius Surgical Technologies Inc.?

Currently, no hedge funds are holding shares in TSE:ASTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aquarius Surgical Technologies Inc.

Aquarius Surgical Technologies (ASTI) is a pioneering company in the medical device sector, specializing in advanced surgical solutions designed to enhance patient outcomes and streamline surgical procedures. The company focuses on developing innovative technologies for minimally invasive surgeries, including a range of surgical instruments, robotic systems, and imaging solutions that cater to various medical fields such as orthopedics, cardiology, and general surgery. ASTI is committed to improving surgical efficiency and safety through its cutting-edge products and comprehensive support services.